Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. Why did this happen? For more information you can review our Terms of Service and Cookie Policy. Eliquis, which made up about 21% of the companys total sales in the latest reported quarter, faces U.S. market exclusivity loss after 2026. Eliquis, which made up about 21% of the companys total sales in the latest reported quarter, faces U.S. market exclusivity loss after 2026.
Eliquis is a male company.
( z0 company :name ( z1 name :op "Eliquis" ) :mod ( z2 male ) )
(z0 / company
    :name (z1 / name
              :op1 "Eliquis")
    :mod (z2 / male))
Eliquis is a male company .
z1 :op1 0
z0 :mod z2
z0 :name z1